MedPath

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1891-01-01
Employees
10K
Market Cap
-
Website
http://www.medschool.wustl.edu

Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response

Phase 1
Active, not recruiting
Conditions
Heart Failure
Interventions
First Posted Date
2016-06-13
Last Posted Date
2024-02-09
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
42
Registration Number
NCT02797184
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

The Role of Brown Adipose Tissue in Triglyceride Clearance in People

Not Applicable
Completed
Conditions
Obesity
Interventions
Other: Cold exposure
Other: Exposure to thermoneutral conditions
First Posted Date
2016-05-30
Last Posted Date
2022-03-15
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
29
Registration Number
NCT02786251
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Phase 2
Recruiting
Conditions
Acute Myeloid Leukemia
Interventions
Procedure: Leukapheresis
Procedure: Graft cell infusion
Drug: Tacrolimus
Drug: Mycophenolate mofetil
Drug: G-CSF
Procedure: CIML NK cell infusion
Drug: ALT-803
First Posted Date
2016-05-25
Last Posted Date
2024-08-06
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
60
Registration Number
NCT02782546
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Shared Decision Making in Older Adults With Distal Radius Fractures

Not Applicable
Terminated
Conditions
Radius Fracture
Interventions
Other: Decision Aid
First Posted Date
2016-05-25
Last Posted Date
2019-01-10
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
32
Registration Number
NCT02782299
Locations
🇺🇸

Washington University-St Louis, Saint Louis, Missouri, United States

Temozolomide Chronotherapy for High Grade Glioma

Phase 2
Completed
Conditions
Glioma
Glioblastoma Multiforme
Interventions
Drug: Temozolomide
Other: Functional Assessment of Cancer Therapy - Brain
Other: ActTrust Condor Instrument Watch
First Posted Date
2016-05-24
Last Posted Date
2024-07-29
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
42
Registration Number
NCT02781792
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Assessing Change in Patient-reported Quality of Life After Elective Surgery: an Observational Comparison Study

Completed
Conditions
Quality of Life
Surgical Procedure, Unspecified
Interventions
Other: Quality of life survey
First Posted Date
2016-05-13
Last Posted Date
2019-02-12
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
17850
Registration Number
NCT02771964
Locations
🇺🇸

Department of Anesthesiology, Saint Louis, Missouri, United States

Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis

Phase 4
Terminated
Conditions
Uveitis
Interventions
First Posted Date
2016-05-12
Last Posted Date
2018-10-01
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
2
Registration Number
NCT02769702
Locations
🇺🇸

Washington University in St. Louis, Saint Louis, Missouri, United States

A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation

Not Applicable
Completed
Conditions
Contraception
Interventions
Other: usual care
Other: 3-week visit
First Posted Date
2016-05-11
Last Posted Date
2019-01-08
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
200
Registration Number
NCT02769676
Locations
🇺🇸

Washington University in St Louis, Saint Louis, Missouri, United States

Violence Prevention for Adolescent Girls With Prior Maltreatment

Not Applicable
Completed
Conditions
PTSD
Depression
Victimization
Aggression
Interventions
Behavioral: GAIN Program
First Posted Date
2016-05-06
Last Posted Date
2016-05-06
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
312
Registration Number
NCT02765048
Locations
🇺🇸

Children's Advocacy Services of Greater St. Louis, St. Louis, Missouri, United States

🇺🇸

Washington University, St. Louis, Missouri, United States

🇺🇸

Comtrea, Arnold, Missouri, United States

BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma

Phase 2
Terminated
Conditions
T-Acute Lymphoblastic Leukemia
Adult T Lymphoblastic Lymphoma
Interventions
Drug: BL-8040
Drug: Nelarabine
First Posted Date
2016-05-05
Last Posted Date
2023-10-31
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
12
Registration Number
NCT02763384
Locations
🇺🇸

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath